Date & Time
Wednesday, October 28, 2026, 10:30 AM - 11:00 AM
Name
477b Implementing Buprenorphine-Naloxone for Opioid Use Disorder in Adolescents
Description
Youth with opioid use disorder need treatment approaches tailored to adolescent development and correctional environments. This session examines the implementation of an OUD program across a statewide juvenile corrections system. Explore buprenorphine-naloxone induction, withdrawal management, interdisciplinary collaboration, and practical strategies that help organizations build institutional support for evidence-based treatment.
Educational Objectives
- Summarize evidence supporting MOUD implementation in adolescent correctional care
- Identify acute opioid withdrawal and management strategies
- Discuss medications used to manage acute opioid withdrawal and opioid use disorder
Level: Advanced
Speakers